Eastern Bank’s Moderna MRNA Stock Holding History

Eastern Bank’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.02M	Hold	14,578	–	–	0.02%	205
2026 Q1	$741K	Hold	14,578	–	–	0.01%	231
2025 Q4	$430K	Hold	14,578	–	–	0.01%	272
2025 Q3	$377K	Hold	14,578	–	–	0.01%	288
2025 Q2	$402K	Hold	14,578	–	–	0.01%	277
2025 Q1	$413K	Hold	14,578	–	–	0.01%	286
2024 Q4	$606K	Hold	14,578	–	–	0.01%	253
2024 Q3	$974K	Buy	14,578 +334	+2%	+$30.7K	0.02%	227
2024 Q2	$1.69M	Hold	14,244	–	–	0.07%	116
2024 Q1	$1.52M	Buy	14,244 +50	+0.4%	+$5.04K	0.06%	128
2023 Q4	$1.41M	Sell	14,194 -175	-1%	-$14.7K	0.06%	125
2023 Q3	$1.48M	Hold	14,369	–	–	0.07%	121
2023 Q2	$1.75M	Sell	14,369 -10,000	-41%	-$1.33M	0.08%	114
2023 Q1	$3.74M	Sell	24,369 -9,475	-28%	-$1.56M	0.19%	92
2022 Q4	$6.08M	Sell	33,844 -9,306	-22%	-$1.52M	0.32%	74
2022 Q3	$5.1M	Sell	43,150 -15,000	-26%	-$2.28M	0.29%	76
2022 Q2	$8.31M	Sell	58,150 -17,500	-23%	-$2.5M	0.44%	72
2022 Q1	$13M	Sell	75,650 -10,000	-12%	-$1.68M	0.6%	61
2021 Q4	$21.8M	Sell	85,650 -12,500	-13%	-$3.65M	0.95%	48
2021 Q3	$37.8M	Sell	98,150 -2,692	-3%	-$993K	1.82%	10
2021 Q2	$23.7M	Buy	+100,842	New	+$18M	1.16%	29

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Eastern Bank's MRNA Position: Q2 2026 in Review

Eastern Bank held its Moderna (MRNA) position steady in Q2 2026 at 14,578 shares worth $1.02M. The position accounts for 0.02% of the portfolio, ranked #205.

Eastern Bank first reported a position in MRNA in Q2 2021 and has held it in 21 quarters since. The position peaked at $37.8M in Q3 2021. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Eastern Bank held 14,578 shares of Moderna worth $1.02M as of Q2 2026.
Eastern Bank left its Moderna share count unchanged in Q2 2026.
Moderna made up 0.02% of Eastern Bank's portfolio in Q2 2026, its #205 holding.
Eastern Bank first reported a position in Moderna in Q2 2021 and has held it in 21 quarters since.
Eastern Bank's Moderna position peaked at $37.8M in Q3 2021.
777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.